Global /China /Basic Materials /Specialty Chemicals /301246
chevron_leftBack
Hubei Hongyuan Pharmaceutical Technology Co., Ltd. logo

Hubei Hongyuan Pharmaceutical Technology Co., Ltd.

301246
SHE: 301246 Delayed
25.89CNY 2.7%
3.83 USD
As of 18 June 2026, Hubei Hongyuan Pharmaceutical Technology Co., Ltd. has a market cap of $1.52B USD, ranking #8416 globally and #2173 in China. It ranks #840 in the Basic Materials sector, and #249 in the Specialty Chemicals industry.
Global Rank
8416
Country Rank
2173
Sector Rank
840
Industry Rank
249
Key Stats
Market Cap
$1.52BUSD
10.27B CNY
Enterprise Value
$1.36BUSD
9.2B CNY
Revenue (TTM)
$287.01MUSD
1.94B CNY
EBITDA (TTM)
$56.22MUSD
379.92M CNY
Net Income (TTM)
$17.62MUSD
119.05M CNY
EBITDA Margin
20%
Profit Margin
6.1%
PE Ratio
86.3
PS Ratio
5.3
PB Ratio
2.3
EV/EBITDA
23.9
Company Profile
Country (HQ)
Sector
Basic Materials
Industry
Specialty Chemicals
CEO
Shuangxi Xu open_in_new
Employees
2,169
Founded
2002
Website
hbhypharm.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2.7% 8.3% 13% 19% 44% 103%

News

Loading...

Markets

Exchange Ticker Price
Shenzhen Stock Exchange
MIC: XSHE
PRIMARY
301246
湖北省宏源药业科技股份有限公司 Ordinary Shares - Class A
ISIN: CNE100005ZB9
Shares Out.:
41.172M1 Shares Float: 34.081M2
TV:
SA:
YF:
GF:
BA:
MS:
25.89 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Hubei Hongyuan Pharmaceutical Technology Co., Ltd.

Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical products in China and internationally. The company offers active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including imidazole, glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, guanine, diacetyl guanine, and diacetylacyclovir; organic chemical raw materials comprising glyoxal, and oxalic acid; and new energy materials consisting of lithium hexafluorophosphate. It also is involved in the production and sales of triamines, guanine and other products; research and development, production, and sales of pharmaceutical preparations; trading of APIS, pharmaceutical intermediates, organic chemical raw materials, etc.; fluoride salts and other fluorine-containing chemical products; and pharmaceutical wholesale, retail, etc. Hubei Hongyuan Pharmaceutical Technology Co., Ltd. was founded in 2002 and is headquartered in Huanggang, China.

Similar Companies

Industry: Specialty Chemicals (China)
Name
Market Cap diff.
PE
$41.48B
280.3B CNY
3K%
21.3
$33.5B
226.4B CNY
2K%
18.0
$27.26B
184.19B CNY
2K%
67.3
$25.81B
174.39B CNY
2K%
47.3
$23.15B
156.41B CNY
1K%
17.4
600176
$20.97B
141.68B CNY
1K%
37.3
Industry: Specialty Chemicals (Global)
Name
Market Cap diff.
PE
LIN
$233.88B
15K%
34.5
$121.68B
104.79B EUR
8K%
29.9
$81.95B
13.15T JPY
5K%
28.0
$77.94B
5K%
30.5
ECL
$72.47B
5K%
34.7
$67.35B
4K%
-
chevron_leftBack